467. Deputy Caoimhghín Ó Caoláin asked the Minister for Health the reason for the uncertainty of supply of the drug Respreeza that is critical to the continued treatment of those alpha 1 sufferers who have been in receipt of the therapy; the steps he will take to remove doubt or fear regarding continuity of supply; the steps taken and commitment to date in 2017 to ensure access to Respreeza for those persons not in receipt of the drug; and if he will make a statement on the matter. [31489/17]

Summary

467. Deputy Caoimhghín Ó Caoláin asked the Minister for Health the reason for the uncertainty of supply of the drug Respreeza that is critical to the continued treatment of those alpha 1 sufferers who have been in receipt of the therapy; the steps he will take to remove doubt or fear regarding continuity of supply; the steps taken and commitment to date in 2017 to ensure access to Respreeza for those persons not in receipt of the drug; and if he will make a statement on the matter. [31489/17]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Availability

  xml · EN · 4 July 2017

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.